Report Detail
Global Gastrointestinal Market Insights, Forecast to 2025
- RnM3048786 |
- 01 March, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
The global Gastrointestinal market is valued at 33600 million US$ in 2018 and will reach 35800 million US$ by the end of 2025, growing at a CAGR of 0.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gastrointestinal market based on company, product type, end user and key regions.
This report studies the global market size of Gastrointestinal in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastrointestinal in these regions.
This research report categorizes the global Gastrointestinal market by top players/brands, region, type and end user. This report also studies the global Gastrointestinal market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market size by Product
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market size by End User
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Gastrointestinal market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Gastrointestinal market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastrointestinal companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gastrointestinal submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Gastrointestinal are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastrointestinal market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Gastrointestinal Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Gastrointestinal Market Size Growth Rate by Product
- 1.4.2 Prescription Gastrointestinal Drug
- 1.4.3 OTC Gastrointestinal Drug
- 1.5 Market by End User
- 1.5.1 Global Gastrointestinal Market Size Growth Rate by End User
- 1.5.2 Chronic Gastritis
- 1.5.3 Functional Dyspepsia
- 1.5.4 Peptic Ulcer
- 1.5.5 Acute Gastroenteritis
- 1.5.6 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Gastrointestinal Market Size
- 2.1.1 Global Gastrointestinal Revenue 2014-2025
- 2.1.2 Global Gastrointestinal Sales 2014-2025
- 2.2 Gastrointestinal Growth Rate by Regions
- 2.2.1 Global Gastrointestinal Sales by Regions
- 2.2.2 Global Gastrointestinal Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Gastrointestinal Sales by Manufacturers
- 3.1.1 Gastrointestinal Sales by Manufacturers
- 3.1.2 Gastrointestinal Sales Market Share by Manufacturers
- 3.1.3 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
- 3.2 Gastrointestinal Revenue by Manufacturers
- 3.2.1 Gastrointestinal Revenue by Manufacturers (2014-2019)
- 3.2.2 Gastrointestinal Revenue Share by Manufacturers (2014-2019)
- 3.3 Gastrointestinal Price by Manufacturers
- 3.4 Gastrointestinal Manufacturing Base Distribution, Product Types
- 3.4.1 Gastrointestinal Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Gastrointestinal Product Type
- 3.4.3 Date of International Manufacturers Enter into Gastrointestinal Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Gastrointestinal Sales by Product
- 4.2 Global Gastrointestinal Revenue by Product
- 4.3 Gastrointestinal Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Gastrointestinal Breakdown Data by End User
6 North America
- 6.1 North America Gastrointestinal by Countries
- 6.1.1 North America Gastrointestinal Sales by Countries
- 6.1.2 North America Gastrointestinal Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Gastrointestinal by Product
- 6.3 North America Gastrointestinal by End User
7 Europe
- 7.1 Europe Gastrointestinal by Countries
- 7.1.1 Europe Gastrointestinal Sales by Countries
- 7.1.2 Europe Gastrointestinal Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Gastrointestinal by Product
- 7.3 Europe Gastrointestinal by End User
8 Asia Pacific
- 8.1 Asia Pacific Gastrointestinal by Countries
- 8.1.1 Asia Pacific Gastrointestinal Sales by Countries
- 8.1.2 Asia Pacific Gastrointestinal Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Gastrointestinal by Product
- 8.3 Asia Pacific Gastrointestinal by End User
9 Central & South America
- 9.1 Central & South America Gastrointestinal by Countries
- 9.1.1 Central & South America Gastrointestinal Sales by Countries
- 9.1.2 Central & South America Gastrointestinal Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Gastrointestinal by Product
- 9.3 Central & South America Gastrointestinal by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Gastrointestinal by Countries
- 10.1.1 Middle East and Africa Gastrointestinal Sales by Countries
- 10.1.2 Middle East and Africa Gastrointestinal Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Gastrointestinal by Product
- 10.3 Middle East and Africa Gastrointestinal by End User
11 Company Profiles
- 11.1 AstraZenec
- 11.1.1 AstraZenec Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZenec Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZenec Gastrointestinal Products Offered
- 11.1.5 AstraZenec Recent Development
- 11.2 Sanofi
- 11.2.1 Sanofi Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi Gastrointestinal Products Offered
- 11.2.5 Sanofi Recent Development
- 11.3 Bayer
- 11.3.1 Bayer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bayer Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bayer Gastrointestinal Products Offered
- 11.3.5 Bayer Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Gastrointestinal Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 GlaxoSmithKline
- 11.5.1 GlaxoSmithKline Company Details
- 11.5.2 Company Business Overview
- 11.5.3 GlaxoSmithKline Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 GlaxoSmithKline Gastrointestinal Products Offered
- 11.5.5 GlaxoSmithKline Recent Development
- 11.6 Teva
- 11.6.1 Teva Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Teva Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Teva Gastrointestinal Products Offered
- 11.6.5 Teva Recent Development
- 11.7 Zeria（Tillotts）
- 11.7.1 Zeria（Tillotts） Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Zeria（Tillotts） Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Zeria（Tillotts） Gastrointestinal Products Offered
- 11.7.5 Zeria（Tillotts） Recent Development
- 11.8 Perrigo
- 11.8.1 Perrigo Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Perrigo Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Perrigo Gastrointestinal Products Offered
- 11.8.5 Perrigo Recent Development
- 11.9 Boehringer Ingelheim
- 11.9.1 Boehringer Ingelheim Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Boehringer Ingelheim Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Boehringer Ingelheim Gastrointestinal Products Offered
- 11.9.5 Boehringer Ingelheim Recent Development
- 11.10 Purdue Pharma
- 11.10.1 Purdue Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Purdue Pharma Gastrointestinal Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Purdue Pharma Gastrointestinal Products Offered
- 11.10.5 Purdue Pharma Recent Development
- 11.11 C.B. Fleet
- 11.12 Abbott
- 11.13 Jiangzhong
- 11.14 Xian-Janssen
12 Future Forecast
- 12.1 Gastrointestinal Market Forecast by Regions
- 12.1.1 Global Gastrointestinal Sales Forecast by Regions 2019-2025
- 12.1.2 Global Gastrointestinal Revenue Forecast by Regions 2019-2025
- 12.2 Gastrointestinal Market Forecast by Product
- 12.2.1 Global Gastrointestinal Sales Forecast by Product 2019-2025
- 12.2.2 Global Gastrointestinal Revenue Forecast by Product 2019-2025
- 12.3 Gastrointestinal Market Forecast by End User
- 12.4 North America Gastrointestinal Forecast
- 12.5 Europe Gastrointestinal Forecast
- 12.6 Asia Pacific Gastrointestinal Forecast
- 12.7 Central & South America Gastrointestinal Forecast
- 12.8 Middle East and Africa Gastrointestinal Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Gastrointestinal Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Gastrointestinal . Industry analysis & Market Report on Gastrointestinal is a syndicated market report, published as Global Gastrointestinal Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Gastrointestinal market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
